Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

TOT Biopharm Opens Suzhou Production Facility



Published December 3, 2012
Related Searches: Filling GMP
TOT Biopharm Co. Ltd. has completed the first stage of construction of its $100 million factory complex in eastern China's Suzhou Industrial Park. The 50,000-sq.-m. facility complex specializes in the R&D, production and marketing of anti-cancer drugs globally. The company's core products include liposomal technology-based specialty drugs, biologics and innovative drugs.
 
The first stage of the new factory complex includes an oral anti-cancer drug plant with separate production facilities for cytotoxics and non-cytotoxics, an injected anti-cancer drug plant, and a GMP pilot plant with 500L cell culture/ purification/filling capacity. The company will begin the second-stage of construction to expand its production scale.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On